Wie am Mittwochabend bekannt wurde, ist erstmals ein Mensch gestorben, der mit dem Vogelgrippevirus A (H5N2) infiziert war. Das bestätigte die Weltgesundheitsorganisation, die zugleich betonte, das ...
Moderna-Aktie für 0 € Ordergebühr (zzgl. Spreads) handeln – hier informieren ...
Moderna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for Covid-19 shots ...
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and directed simulation. The Fibre Channel VIP provides full protocol ...
Nachrichten » Developers Of MRNA Covid Vaccines Win WHO Award For Global Health Push Mitteilungen FN als Startseite AFX News 28.05.2024 13:00 Uhr 115 Leser Artikel bewerten: (0) ...
The Food and Drug Administration on Friday approved a third vaccine for respiratory syncytial virus, clearing a shot from biotechnology company Moderna one year after granting a green light to ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Moderna has received its second drug approval from US regulators for an RSV vaccine in older adults, a step ...
Moderna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a messenger RNA vaccine has been approved ...
Moderna Inc. gained U.S. approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for COVID-19 shots. The ...
Für die Papiere des Impfstoffherstellers Novavax ging es am Donnerstag im vorbörslichen US-Handel zunächst steil nach oben. Nachdem die Novavax-Aktien bereits gestern den Handel an der NASDAQ mit ...